Colleen Kusy
Stock Analyst at Baird
(0.61)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLYM Climb Bio | Initiates Coverage On: Outperform | 9 | 1.65 | 445.45% | 1 | Aug 15, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Outperform | 47 50 | 23.87 | 109.47% | 12 | Jul 18, 2025 | |
NUVL Nuvalent | Maintains: Outperform | 105 112 | 74.98 | 49.37% | 2 | Jun 25, 2025 | |
ELVN Enliven Therapeutics | Maintains: Outperform | 40 52 | 18.11 | 187.13% | 3 | Jun 16, 2025 | |
AGEN Agenus | Maintains: Neutral | 4 6 | 4.27 | 40.52% | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 41 | 17.99 | 127.9% | 4 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 6 | 0.88 | 581.82% | 5 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 65 | 15.22 | 327.07% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 100 75 | 5.98 | 1154.18% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | 12.56 | 35.35% | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 27 25 | 9.19 | 172.03% | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 40 | 39.95 | 0.13% | 3 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 15 | 15 | 0% | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 255 210 | 3.73 | 5530.03% | 1 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 1.97 | 1625.89% | 5 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 230 | 1.96 | 11634.69% | 1 | Nov 2, 2021 |